Nitazoxanide for chronic hepatitis C-Reference-Cited by-同舟云学术

Nitazoxanide for chronic hepatitis C

Published:2014-04-06 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Nikolova Kristiana¹,Gluud Christian¹,Grevstad Berit²,Jakobsen Janus C¹

Affiliation:

1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100

2. Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812; Blegdamsvej 9 Dept 78.22 Copenhagen Denmark DK-2100

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD009182.pub2/fullpdf

Reference138 articles.

1. A phase II, randomized, double-blind, placebo-controlled study of nitazoxanide plus peginterferon and ribavirin in naive patients with chronic hepatitis C genotype 1 infection: final report;Bacon;Gastroenterology,2010

2. Phase 2 randomized, double-blind, placebo-controlled study of nitazoxanide plus peginterferon and ribavirin in HCV genotype 1 naive patients: week 12 sustained virological response rate;Bacon;Journal of Hepatology,2010

3. Phase 2 randomized, double-blind, placebo-controlled study of nitazoxanide plus peginterferon and ribavirin in HCV genotype 1 patients: interim analysis shows increase in EVR;Bacon;Journal of Hepatology,2009

4. Berrie C Combined thiazolide nitazoxanide plus PEG-IFN Alfa-2a/ribavirin improved viral response in HCV genotype 1: presented at EASL 2010 http://www.firstwordpharma.com/node/604408?tsid=17#axzz2y2MTgiDa

5. NCT00637923 Study of nitazoxanide, peginterferon alfa-2a and ribavirin in treatment-naive hepatitis C patients (STEALTH-3) http://clinicaltrials.gov/show/NCT00637923

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological efficacy and potential of the use of nitazoxanide, a thiazolide drug with a wide spectrum of action;Reviews on Clinical Pharmacology and Drug Therapy;2024-04-27

2. Nitazoxanide reduces inflammation and bone erosion in mice with collagen-induced arthritis via inhibiting the JAK2/STAT3 and NF-κB pathways in fibroblast-like synoviocytes;Biomedicine & Pharmacotherapy;2024-02

3. Nitazoxanide and COVID-19: A review;Molecular Biology Reports;2022-09-12

4. Human Astroviruses: A Tale of Two Strains;Viruses;2021-02-27

5. Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective;World Journal of Gastroenterology;2020-12-14